Terms: = Lung cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Clinical Outcome
4 results:
1. Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome.
Lee JH; Yoo SS; Hong MJ; Choi JE; Kim S; Kang HG; Do SK; Kim JH; Baek SA; Lee WK; Do Yoo J; Choi SH; Lee YH; Seo H; Lee J; Lee SY; Cha SI; Kim CH; Park JY
Sci Rep; 2021 Jan; 11(1):1794. PubMed ID: 33469055
[TBL] [Abstract] [Full Text] [Related]
2. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.
Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C
Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370
[TBL] [Abstract] [Full Text] [Related]
3. Thoracoscopic half carina resection and bronchial sleeve resection for central lung cancer.
Xu X; Chen H; Yin W; Shao W; Xiong X; Huang J; He J
Surg Innov; 2014 Oct; 21(5):481-6. PubMed ID: 24292264
[TBL] [Abstract] [Full Text] [Related]
4. Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004.
Isa S; Kawaguchi T; Teramukai S; Minato K; Ohsaki Y; Shibata K; Yonei T; Hayashibara K; Fukushima M; Kawahara M; Furuse K; Mack PC
J Thorac Oncol; 2009 Sep; 4(9):1104-10. PubMed ID: 19620934
[TBL] [Abstract] [Full Text] [Related]
